Preparation and evaluation of Vinpocetine self-emulsifying pH gradient release pellets

References

• Abdalla A, Mader K. (2007). Preparation and characterization of a self-emulsifying pellet formulation. Eur J Pharm Biopharm 66:220–6.
   PubMed Web of Science ®Google Scholar
• Agrawal U, Sharma R, Gupta M, Vyas SP. (2014). Is nanotechnology a boon for oral drug delivery? Drug Discov Today 19:1530–46.
   PubMed Web of Science ®Google Scholar
• Aho J, Halme A, Boetker J, et al. (2017). The effect of HPMC and MC as pore formers on the rheology of the implant microenvironment and the drug release in vitro. Carbohydrate Polymers 177:433–42.
   PubMed Web of Science ®Google Scholar
• Aungst BJ. (1993). Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. Cheminform 82:979–87.
   Google Scholar
• Bereczki D, Fekete I. (1999). A systematic review of vinpocetine therapy in acute ischaemic stroke. Eur J Clin Pharmacol 55:349.
   PubMed Web of Science ®Google Scholar
• Chen L, Okuda T, Lu XY, Chan HK. (2016). Amorphous powders for inhalation drug delivery. Adv Drug Deliv Rev 100:102–15.
   PubMed Web of Science ®Google Scholar
• Cole ET, Scott RA, Connor AL, et al. (2001). Enteric coated HPMC capsules designed to achieve intestinal targeting. Int J Pharm 231:83–95.
   Web of Science ®Google Scholar
• Cui SX, Nie SF, Li L, et al. (2009). Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine. Drug Dev Ind Pharm 35:603–11.
   PubMed Web of Science ®Google Scholar
• Curatolo W, Nightingale JA, Herbig SM. (2009). Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu. Pharm Res 26:1419–31.
   PubMed Web of Science ®Google Scholar
• Ding J, Li J, Mao S. (2015). Development and evaluation of vinpocetine inclusion complex for brain targeting. Asian J Pharm Sci 10:114–20.
   Web of Science ®Google Scholar
• Dokania S, Joshi AK. (2015). Self-microemulsifying drug delivery system (SMEDDS)-challenges and road ahead. Drug Deliv 22:675–90.
   PubMed Web of Science ®Google Scholar
• Doshi HA, Shrivastava R. (1993). Preparation of pellets: extruding and spheronizing machines study. Indian J Pharm Sci 55:58.
   Google Scholar
• Feng M, Betti M. (2017). Transepithelial transport efficiency of bovine collagen hydrolysates in a human Caco-2 cell line model. Food Chem 224:242–50.
   PubMed Web of Science ®Google Scholar
• Grove M, Mullertz A, Nielsen JL, Pedersen GP. (2006). Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides. Eur J Pharm Sci 28:233–42.
   PubMed Web of Science ®Google Scholar
• Gursoy RN, Benita S. (2004). Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 58:173–82.
   PubMed Web of Science ®Google Scholar
• Hu LD, Liu Y, Tang X, Zhang Q. (2006). Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets. Eur J Pharm Biopharm 64:185–92.
   PubMed Web of Science ®Google Scholar
• Ji C, Xu H, Wu W. (2007). In vitro evaluation and pharmacokinetics in dogs of guar gum and Eudragit FS30D-coated colon-targeted pellets of indomethacin. J Drug Target 15:123–31.
   PubMed Web of Science ®Google Scholar
• Jincai W, Tingfang D, Yongheng Z, et al. (2014). Effects of vinpocetine and ozagrel on behavioral recovery of rats after global brain ischemia. J Clin Neurosci 21:661–3.
   PubMed Web of Science ®Google Scholar
• Kang BK, Lee JS, Chon SK, et al. (2004). Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 274:65–73.
   PubMed Web of Science ®Google Scholar
• Kommuru TR, Gurley B, Khan MA, Reddy IK. (2001). Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm 212:233–46.
   PubMed Web of Science ®Google Scholar
• Krupa A, Jachowicz R, Kurek M, et al. (2014). Preparation of solid self-emulsifying drug delivery systems using magnesium aluminometasilicates and fluid-bed coating process. Powder Technol 266:329–39.
   Web of Science ®Google Scholar
• Luo Y, Chen D, Ren L, et al. (2006). Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J Control Release 114:53–9.
   PubMed Web of Science ®Google Scholar
• Miriyala N, Ouyang D, Perrie Y, et al. (2017). Activated carbon as a carrier for amorphous drug delivery: effect of drug characteristics and carrier wettability. Eur J Pharm Biopharm 115:197–205.
   PubMed Web of Science ®Google Scholar
• Morgen M, Saxena A, Chen XQ, et al. (2017). Lipophilic salts of poorly soluble compounds to enable high-dose lipidic SEDDS formulations in drug discovery. Eur J Pharm Biopharm 117:212–23.
   PubMed Web of Science ®Google Scholar
• Nazzal S, Nutan M, Palamakula A, et al. (2002). Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients. Int J Pharm 240:103–14.
   PubMed Web of Science ®Google Scholar
• Newton JM, Pinto MR, Podczeck F. (2007). The preparation of pellets containing a surfactant or a mixture of mono- and di-gylcerides by extrusion/spheronization. Eur J Pharm Sci 30:333–42.
   PubMed Web of Science ®Google Scholar
• Patra CN, Priya R, Swain S, et al. (2017). Pharmaceutical significance of Eudragit: a review. Future J Pharm Sci 3:33–45.
   Web of Science ®Google Scholar
• Patyar S, Prakash A, Modi M, Medhi B. (2011). Role of vinpocetine in cerebrovascular diseases. Pharmacol Rep 63:618
   PubMed Web of Science ®Google Scholar
• Pichardo S, Devesa V, Puerto M, et al. (2017). Intestinal transport of cylindrospermopsin using the caco-2 cell line. Toxicol in Vitro 38:142–9.
   PubMed Web of Science ®Google Scholar
• Qi X, Qin J, Ma N, et al. (2014). Solid self-microemulsifying dispersible tablets of celastrol: formulation development, charaterization and bioavailability evaluation. Int J Pharm 472:40–7.
   PubMed Web of Science ®Google Scholar
• Ribeiro LSS, Ferreira DC, Veiga FJB. (2003). Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with β-cyclodextrin and its sulfobutyl ether derivative in solution and solid state. Eur J Pharm Sci 20:253–66.
   PubMed Web of Science ®Google Scholar
• Rujivipat S, Bodmeier R. (2012). Moisture plasticization for enteric Eudragit® L30D-55-coated pellets prior to compression into tablets. Eur J Pharm Biopharm 81:223–9.
   PubMed Web of Science ®Google Scholar
• Sha X, Fang X. (2004). Transport characteristics of 9-nitrocamptothecin in the human intestinal cell line caco-2 and everted gut sacs. Int J Pharm 272:161–71.
   PubMed Web of Science ®Google Scholar
• Sha X, Yan G, Wu Y, et al. (2005). Effect of self-microemulsifying drug delivery systems containing labrasol on tight junctions in caco-2 cells. Eur J Pharm Sci 24:477–86.
   PubMed Web of Science ®Google Scholar
• Wang Z, Sun J, Wang Y, et al. (2010). Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation. Int J Pharm 383:1–6.
   PubMed Web of Science ®Google Scholar
• Wei Y, Ye X, Shang X, et al. (2012). Enhanced oral bioavailability of silybin by a supersaturatable self-emulsifying drug delivery system (S-SEDDS). Colloids and Surfaces A Physicochem Eng Aspects 396:22–8.
   Web of Science ®Google Scholar
• Yang M, Cui F, You B, et al. (2004a). A novel pH-dependent gradient-release delivery system for nitrendipine II. Investigations of the factors affecting the release behaviors of the system. Int J Pharm 286:99–109.
   PubMed Web of Science ®Google Scholar
• Yang M, Cui F, You B, et al. (2004b). A novel pH-dependent gradient-release delivery system for nitrendipine: I. Manufacturing, evaluation in vitro and bioavailability in healthy dogs. J Control Release 98:219–29.
   PubMed Web of Science ®Google Scholar